The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
BTK 抑制剂 ARQ 531 靶向治疗对伊布替尼耐药的慢性淋巴细胞白血病 (CLL) 和 Richter 转化
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-17-1409
Sean D Reiff, Rose Mantel, Lisa L Smith, J T Greene, Elizabeth M Muhowski, Catherine A Fabian, Virginia M Goettl, Minh Tran, Bonnie K Harrington, Kerry A Rogers, Farrukh T Awan, Kami Maddocks, Leslie Andritsos, Amy M Lehman, Deepa Sampath, Rosa Lapalombella, Sudharshan Eathiraj, Giovanni Abbadessa,